Comparison of healthcare resource utilization and costs in patients with type 2 diabetes initiating dapagliflozin versus sitagliptin

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - September 10, 2018 Category: Endocrinology Authors: Emily D. Parker PhD , Eric T. Wittbrodt PharmD , Jeffrey T. McPheeters , Juan P. Frias MD Source Type: research